302 related articles for article (PubMed ID: 37465879)
1. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
[TBL] [Abstract][Full Text] [Related]
2. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
3. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
4. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
Lépine S; Castellanos-Montiel MJ; Durcan TM
Transl Neurodegener; 2022 Dec; 11(1):56. PubMed ID: 36575535
[TBL] [Abstract][Full Text] [Related]
5. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).
Alhindi A; Boehm I; Chaytow H
J Anat; 2022 Nov; 241(5):1089-1107. PubMed ID: 34101196
[TBL] [Abstract][Full Text] [Related]
6. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
8. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB; Hobo B; De Winter F; Verhaagen J
PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
10. Epothilone D accelerates disease progression in the SOD1
Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
[TBL] [Abstract][Full Text] [Related]
11. Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Carrasco DI; Seburn KL; Pinter MJ
Exp Neurol; 2016 Jan; 275 Pt 1(0 1):172-81. PubMed ID: 26416261
[TBL] [Abstract][Full Text] [Related]
12. Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.
Carrasco DI; Bahr BA; Seburn KL; Pinter MJ
Exp Neurol; 2016 Apr; 278():116-26. PubMed ID: 26853136
[TBL] [Abstract][Full Text] [Related]
13. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.
Arbour D; Tremblay E; Martineau É; Julien JP; Robitaille R
J Neurosci; 2015 Jan; 35(2):688-706. PubMed ID: 25589763
[TBL] [Abstract][Full Text] [Related]
14. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
15. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
16. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS.
Gould TW; Buss RR; Vinsant S; Prevette D; Sun W; Knudson CM; Milligan CE; Oppenheim RW
J Neurosci; 2006 Aug; 26(34):8774-86. PubMed ID: 16928866
[TBL] [Abstract][Full Text] [Related]
17. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
18. Unaffected motor endplate occupancy in eye muscles of ALS G93A mouse model.
Tjust AE; Brannstrom T; Pedrosa Domellof F
Front Biosci (Schol Ed); 2012 Jun; 4(4):1547-55. PubMed ID: 22652891
[TBL] [Abstract][Full Text] [Related]
19. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
[TBL] [Abstract][Full Text] [Related]
20. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
